TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
RLYB

Rallybio Corp

Healthcare · Biotechnology

17.20$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Rallybio Corp (RLYB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 98 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RLYB
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
133 116 99 92 79 68 58 51 68 62 54 98
132 115 99 91 78 68 57 50 67 61 53 97
19 24 19 17 25 14 15 9.4 32 31 41 93
121 110 94 89 75 66 54 46 59 55 47 93
9.6 9.4 10 12 8.2 6.5 3.9 5.0 4.6 4.3 4.2 3.6
9.4 9.3 10 12 8.2 6.2 3.9 5.0 4.5 4.2 4.1 3.6
0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 –
0.5 1.0 0.5 1.2 0.6 0.3 0.4 0.1 0.3 0.1 0.9 0.8
124 106 89 80 71 62 54 46 63 58 50 94
-215 -235 -254 -271 -282 -293 -302 -312 -296 -302 -310 -267
5.1 5.1 5.1 5.5 5.6 5.6 5.6 5.6 5.6 5.3 5.7 5.8

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?